Insight into Mechanism of Action of Anticancer Benzazoles

Area of Science:

• Biochemistry
• Molecular Biology
• Medicinal Chemistry

Background:

• DNA topoisomerase II (topo II) is a crucial enzyme in managing DNA topology, essential for replication and segregation.
• Inhibiting topo II, a validated anticancer strategy, leads to DNA damage and cell death.
• Topo II poisons stabilize the enzyme-DNA complex, preventing DNA religation and causing strand breaks.

Purpose of the Study:

• To evaluate previously synthesized benzazole derivatives for eukaryotic DNA topoisomerase II inhibitory activity.
• To elucidate the binding interactions between benzazole derivatives and topo II using molecular docking.
• To provide a basis for designing more effective anticancer drugs targeting human topo II.

Main Methods:

• In vitro assessment of DNA topoisomerase II inhibitory activity of benzazole derivatives.
• Comparative molecular docking studies using two distinct docking programs to analyze enzyme-compound interactions.
• Analysis of binding modes and interactions within the DNA binding and cleavage domain of topo II.

Main Results:

• Benzazole derivatives demonstrated inhibitory activity against eukaryotic DNA topoisomerase II.
• Molecular docking studies successfully clarified the binding modes of these compounds to the topo II enzyme.
• The study identified specific interactions crucial for enzyme inhibition.

Conclusions:

• The findings support the potential of benzazole derivatives as anticancer agents targeting topo II.
• This research offers valuable insights for the rational design of novel, potent human topoisomerase II inhibitors.
• The study contributes to the development of new therapeutic strategies for cancer treatment.